Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000905339-11-000012
Filing Date
2011-01-10
Accepted
2011-01-10 14:14:25
Documents
1

Document Format Files

Seq Description Document Type Size
1 biocryst13ga.txt SC 13G/A 10458
  Complete submission text file 0000905339-11-000012.txt   12097
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44055 | Film No.: 11519808
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 40900 GRIMMER BLVD FREMONT CA 94538
Business Address
HARROSH JOSEPH L (Filed by) CIK: 0000905339 (see all company filings)

Type: SC 13G/A